1. Home
  2. ATRC vs CGAU Comparison

ATRC vs CGAU Comparison

Compare ATRC & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • CGAU
  • Stock Information
  • Founded
  • ATRC 2000
  • CGAU 2002
  • Country
  • ATRC United States
  • CGAU Canada
  • Employees
  • ATRC N/A
  • CGAU N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • CGAU Precious Metals
  • Sector
  • ATRC Health Care
  • CGAU Basic Materials
  • Exchange
  • ATRC Nasdaq
  • CGAU Nasdaq
  • Market Cap
  • ATRC 1.7B
  • CGAU 1.6B
  • IPO Year
  • ATRC 2005
  • CGAU N/A
  • Fundamental
  • Price
  • ATRC $35.83
  • CGAU $9.03
  • Analyst Decision
  • ATRC Strong Buy
  • CGAU Buy
  • Analyst Count
  • ATRC 10
  • CGAU 3
  • Target Price
  • ATRC $49.60
  • CGAU $13.33
  • AVG Volume (30 Days)
  • ATRC 416.8K
  • CGAU 1.6M
  • Earning Date
  • ATRC 10-28-2025
  • CGAU 10-30-2025
  • Dividend Yield
  • ATRC N/A
  • CGAU 2.16%
  • EPS Growth
  • ATRC N/A
  • CGAU N/A
  • EPS
  • ATRC N/A
  • CGAU 0.33
  • Revenue
  • ATRC $499,946,000.00
  • CGAU $1,214,156,000.00
  • Revenue This Year
  • ATRC $16.32
  • CGAU $5.89
  • Revenue Next Year
  • ATRC $12.37
  • CGAU $9.41
  • P/E Ratio
  • ATRC N/A
  • CGAU $28.33
  • Revenue Growth
  • ATRC 16.28
  • CGAU N/A
  • 52 Week Low
  • ATRC $25.57
  • CGAU $5.41
  • 52 Week High
  • ATRC $43.11
  • CGAU $9.43
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 50.53
  • CGAU 69.82
  • Support Level
  • ATRC $34.57
  • CGAU $8.61
  • Resistance Level
  • ATRC $38.08
  • CGAU $9.43
  • Average True Range (ATR)
  • ATRC 1.46
  • CGAU 0.25
  • MACD
  • ATRC -0.24
  • CGAU 0.07
  • Stochastic Oscillator
  • ATRC 37.06
  • CGAU 77.14

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About CGAU Centerra Gold Inc.

Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.

Share on Social Networks: